Impacts of host factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression

SARS-CoV-2, identified in Wuhan, China, in December 2019, is the third coronavirus responsible for a global epidemic, following SARS-CoV (2002) and MERS-CoV (2012). Given the recent emergence of COVID-19, comprehensive immunological data are still limited. The susceptibility and severity of SARS-CoV...

Full description

Saved in:
Bibliographic Details
Published in:Journal of immunoassay & immunochemistry 2024-11, Vol.45 (6), p.493-517
Main Authors: Salum, Ghada M., Abd el Meguid, Mai, Fotouh, Basma E., Dawood, Reham M.
Format: Article
Language:English
Subjects:
Biomarkers
Coronaviruses
COVID-19
COVID-19 - immunology
COVID-19 - virology
Disease Progression
Disease Susceptibility
Genetic diversity
Genetic factors
Genetic Predisposition to Disease
genetic variations
host factors
Humans
Immune response
Immune system
Immunology
neuropilin-1
SARS-CoV-2
SARS-CoV-2 - physiology
Severe acute respiratory syndrome coronavirus 2
Therapeutic targets
Viral diseases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SARS-CoV-2, identified in Wuhan, China, in December 2019, is the third coronavirus responsible for a global epidemic, following SARS-CoV (2002) and MERS-CoV (2012). Given the recent emergence of COVID-19, comprehensive immunological data are still limited. The susceptibility and severity of SARS-CoV-2 infection are influenced by various host factors, including hormonal changes, genetic variations, inflammatory biomarkers, and behavioral attitudes. Identifying genetic factors contributing to infection severity may accelerate therapeutic development, including drug repurposing, natural extracts, and post-vaccine interventions (Initiative and Covid, 2021). This review discusses the human protein machinery involved in (a) SARS-CoV-2 host receptors, (b) the human immune response, and (c) the impact of demographic and genetic differences on individual risk for COVID-19. This review aims to clarify host factors implicated in SARS-CoV-2 susceptibility and progression, highlighting potential therapeutic targets and supportive treatment strategies.
ISSN:1532-1819
1532-4230
1532-4230
DOI:10.1080/15321819.2024.2429538